Security Reports > Endocyte

Endocyte
Data Breaches, Cyber Attacks and Security Report

https://endocyte.com  ᛫  Biotech & Pharmaceuticals
Last updated July 2, 2020

Endocyte Security Rating

${grade.letter}
${cstarScore}
/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Endocyte is implementing good security practices.

Company Information

Company:
${companyName}
Valuation:
${marketCap}
Employees:
${employees}
Location:
${country}
CEO:
${ceo}

About Endocyte

Endocyte (NASDAQ: ECYT) is a biopharmaceutical company established in 1996 and headquartered in West Lafayette, Indiana, a resident of the Purdue Research Park. In 2011 the company completed successfully an initial public offering (IPO).


Data Breaches and Security News


Security Report for Endocyte

Want a security rating for your organization?

This report shows a preliminary security rating for Endocyte. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Endocyte's security performance with other companies